Sanofi-Aventis (France)'s Acomplia Wins Approval from UK

PARIS (Reuters) - French drugmaker Sanofi-Aventis said on Wednesday that its troubled obesity-fighting product Acomplia had won approval from the National Institute for Health and Clinical Excellence (NICE).

MORE ON THIS TOPIC